Cachet Pharmaceutical (002462) Stock Overview
Engages in the wholesale, retail, and logistics of pharmaceutical products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
002462 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Cachet Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥15.35 |
| 52 Week High | CN¥19.69 |
| 52 Week Low | CN¥11.25 |
| Beta | 0.48 |
| 1 Month Change | -5.13% |
| 3 Month Change | 1.52% |
| 1 Year Change | 23.10% |
| 3 Year Change | 3.86% |
| 5 Year Change | 10.91% |
| Change since IPO | 9.07% |
Recent News & Updates
Shareholder Returns
| 002462 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | -2.0% | -2.5% | -2.4% |
| 1Y | 23.1% | -2.5% | 26.2% |
Return vs Industry: 002462 exceeded the CN Healthcare industry which returned -2.5% over the past year.
Return vs Market: 002462 underperformed the CN Market which returned 26.2% over the past year.
Price Volatility
| 002462 volatility | |
|---|---|
| 002462 Average Weekly Movement | 8.6% |
| Healthcare Industry Average Movement | 4.9% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in CN Market | 10.0% |
| 10% least volatile stocks in CN Market | 3.2% |
Stable Share Price: 002462's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 002462's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 1,969 | Yibin Huang | www.cachet.com.cn |
Cachet Pharmaceutical Co., Ltd. engages in the wholesale, retail, and logistics of pharmaceutical products in China. The company also offers medical devices. It sells its products through online and offline channels.
Cachet Pharmaceutical Co., Ltd. Fundamentals Summary
| 002462 fundamental statistics | |
|---|---|
| Market cap | CN¥4.48b |
| Earnings (TTM) | CN¥71.03m |
| Revenue (TTM) | CN¥19.99b |
Is 002462 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002462 income statement (TTM) | |
|---|---|
| Revenue | CN¥19.99b |
| Cost of Revenue | CN¥18.65b |
| Gross Profit | CN¥1.33b |
| Other Expenses | CN¥1.26b |
| Earnings | CN¥71.03m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Apr 24, 2026
| Earnings per share (EPS) | 0.24 |
| Gross Margin | 6.67% |
| Net Profit Margin | 0.36% |
| Debt/Equity Ratio | 31.5% |
How did 002462 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/08 04:55 |
| End of Day Share Price | 2026/03/06 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cachet Pharmaceutical Co., Ltd. is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Andy Liu | China Stock Investment Research Co. Ltd. (GZ500..com) |
| Jie Li | Everbright Securities Co. Ltd. |
| Changyan Xie | Guosen Securities Co., Ltd. |